455 related articles for article (PubMed ID: 17575084)
1. Congenital hyperinsulinism associated ABCC8 mutations that cause defective trafficking of ATP-sensitive K+ channels: identification and rescue.
Yan FF; Lin YW; MacMullen C; Ganguly A; Stanley CA; Shyng SL
Diabetes; 2007 Sep; 56(9):2339-48. PubMed ID: 17575084
[TBL] [Abstract][Full Text] [Related]
2. Defective trafficking and function of KATP channels caused by a sulfonylurea receptor 1 mutation associated with persistent hyperinsulinemic hypoglycemia of infancy.
Cartier EA; Conti LR; Vandenberg CA; Shyng SL
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2882-7. PubMed ID: 11226335
[TBL] [Abstract][Full Text] [Related]
3. Sulfonylurea receptor 1 mutations that cause opposite insulin secretion defects with chemical chaperone exposure.
Pratt EB; Yan FF; Gay JW; Stanley CA; Shyng SL
J Biol Chem; 2009 Mar; 284(12):7951-9. PubMed ID: 19151370
[TBL] [Abstract][Full Text] [Related]
4. ABCC8 (SUR1) and KCNJ11 (KIR6.2) mutations in persistent hyperinsulinemic hypoglycemia of infancy and evaluation of different therapeutic measures.
Darendeliler F; Fournet JC; Baş F; Junien C; Gross MS; Bundak R; Saka N; Günöz H
J Pediatr Endocrinol Metab; 2002; 15(7):993-1000. PubMed ID: 12199344
[TBL] [Abstract][Full Text] [Related]
5. Functional analyses of novel mutations in the sulfonylurea receptor 1 associated with persistent hyperinsulinemic hypoglycemia of infancy.
Shyng SL; Ferrigni T; Shepard JB; Nestorowicz A; Glaser B; Permutt MA; Nichols CG
Diabetes; 1998 Jul; 47(7):1145-51. PubMed ID: 9648840
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological Correction of Trafficking Defects in ATP-sensitive Potassium Channels Caused by Sulfonylurea Receptor 1 Mutations.
Martin GM; Rex EA; Devaraneni P; Denton JS; Boodhansingh KE; DeLeon DD; Stanley CA; Shyng SL
J Biol Chem; 2016 Oct; 291(42):21971-21983. PubMed ID: 27573238
[TBL] [Abstract][Full Text] [Related]
7. Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the β-cell sulfonylurea receptor SUR1.
Macmullen CM; Zhou Q; Snider KE; Tewson PH; Becker SA; Aziz AR; Ganguly A; Shyng SL; Stanley CA
Diabetes; 2011 Jun; 60(6):1797-804. PubMed ID: 21536946
[TBL] [Abstract][Full Text] [Related]
8. Severe congenital hyperinsulinism caused by a mutation in the Kir6.2 subunit of the adenosine triphosphate-sensitive potassium channel impairing trafficking and function.
Marthinet E; Bloc A; Oka Y; Tanizawa Y; Wehrle-Haller B; Bancila V; Dubuis JM; Philippe J; Schwitzgebel VM
J Clin Endocrinol Metab; 2005 Sep; 90(9):5401-6. PubMed ID: 15998776
[TBL] [Abstract][Full Text] [Related]
9. Identification of a familial hyperinsulinism-causing mutation in the sulfonylurea receptor 1 that prevents normal trafficking and function of KATP channels.
Taschenberger G; Mougey A; Shen S; Lester LB; LaFranchi S; Shyng SL
J Biol Chem; 2002 May; 277(19):17139-46. PubMed ID: 11867634
[TBL] [Abstract][Full Text] [Related]
10. Hyperinsulinism of infancy: novel ABCC8 and KCNJ11 mutations and evidence for additional locus heterogeneity.
Tornovsky S; Crane A; Cosgrove KE; Hussain K; Lavie J; Heyman M; Nesher Y; Kuchinski N; Ben-Shushan E; Shatz O; Nahari E; Potikha T; Zangen D; Tenenbaum-Rakover Y; de Vries L; Argente J; Gracia R; Landau H; Eliakim A; Lindley K; Dunne MJ; Aguilar-Bryan L; Glaser B
J Clin Endocrinol Metab; 2004 Dec; 89(12):6224-34. PubMed ID: 15579781
[TBL] [Abstract][Full Text] [Related]
11. Genotype-phenotype correlations in children with congenital hyperinsulinism due to recessive mutations of the adenosine triphosphate-sensitive potassium channel genes.
Henwood MJ; Kelly A; Macmullen C; Bhatia P; Ganguly A; Thornton PS; Stanley CA
J Clin Endocrinol Metab; 2005 Feb; 90(2):789-94. PubMed ID: 15562009
[TBL] [Abstract][Full Text] [Related]
12. Carriers of an inactivating beta-cell ATP-sensitive K(+) channel mutation have normal glucose tolerance and insulin sensitivity and appropriate insulin secretion.
Huopio H; Vauhkonen I; Komulainen J; Niskanen L; Otonkoski T; Laakso M
Diabetes Care; 2002 Jan; 25(1):101-6. PubMed ID: 11772909
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of new KATP-channel mutations associated with congenital hyperinsulinism in the Finnish population.
Reimann F; Huopio H; Dabrowski M; Proks P; Gribble FM; Laakso M; Otonkoski T; Ashcroft FM
Diabetologia; 2003 Feb; 46(2):241-9. PubMed ID: 12627323
[TBL] [Abstract][Full Text] [Related]
14. N-terminal transmembrane domain of SUR1 controls gating of Kir6.2 by modulating channel sensitivity to PIP2.
Pratt EB; Tewson P; Bruederle CE; Skach WR; Shyng SL
J Gen Physiol; 2011 Mar; 137(3):299-314. PubMed ID: 21321069
[TBL] [Abstract][Full Text] [Related]
15. Identification and pharmacological correction of a membrane trafficking defect associated with a mutation in the sulfonylurea receptor causing familial hyperinsulinism.
Partridge CJ; Beech DJ; Sivaprasadarao A
J Biol Chem; 2001 Sep; 276(38):35947-52. PubMed ID: 11457841
[TBL] [Abstract][Full Text] [Related]
16. Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1.
Huopio H; Reimann F; Ashfield R; Komulainen J; Lenko HL; Rahier J; Vauhkonen I; Kere J; Laakso M; Ashcroft F; Otonkoski T
J Clin Invest; 2000 Oct; 106(7):897-906. PubMed ID: 11018078
[TBL] [Abstract][Full Text] [Related]
17. A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.
Proks P; Arnold AL; Bruining J; Girard C; Flanagan SE; Larkin B; Colclough K; Hattersley AT; Ashcroft FM; Ellard S
Hum Mol Genet; 2006 Jun; 15(11):1793-800. PubMed ID: 16613899
[TBL] [Abstract][Full Text] [Related]
18. Genetic analysis of Japanese patients with persistent hyperinsulinemic hypoglycemia of infancy: nucleotide-binding fold-2 mutation impairs cooperative binding of adenine nucleotides to sulfonylurea receptor 1.
Tanizawa Y; Matsuda K; Matsuo M; Ohta Y; Ochi N; Adachi M; Koga M; Mizuno S; Kajita M; Tanaka Y; Tachibana K; Inoue H; Furukawa S; Amachi T; Ueda K; Oka Y
Diabetes; 2000 Jan; 49(1):114-20. PubMed ID: 10615958
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations.
Pinney SE; MacMullen C; Becker S; Lin YW; Hanna C; Thornton P; Ganguly A; Shyng SL; Stanley CA
J Clin Invest; 2008 Aug; 118(8):2877-86. PubMed ID: 18596924
[TBL] [Abstract][Full Text] [Related]
20. Characterization of ABCC8 and KCNJ11 gene mutations and phenotypes in Korean patients with congenital hyperinsulinism.
Park SE; Flanagan SE; Hussain K; Ellard S; Shin CH; Yang SW
Eur J Endocrinol; 2011 Jun; 164(6):919-26. PubMed ID: 21422196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
